
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 21, 2025, titled "Emcure Pharmaceuticals to Acquire Remaining Stake in its Subsidiary Zuventus Healthcare Ltd.".
Filed with NSE ·

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 21, 2025, titled "Emcure Pharmaceuticals to Acquire Remaining Stake in its Subsidiary Zuventus Healthcare Ltd.".
6ix hasn’t read this filing yet.
Emcure Pharmaceuticals Limited on 6ix
Follow Emcure Pharmaceuticals into a list and get an email when it puts out news.
Follow Emcure Pharmaceuticals